Fecal microbiota transplantation may transmit COVID-19, FDA warns

The FDA warned clinicians the SARS-CoV-2 virus, which causes COVID-19, may be transmitted in fecal samples during fecal microbiota transplants.

Advertisement

What you should know:

1. Although transmission risk during FMT remains unknown, because of the possibility, the FDA has recommended additional safety precautions.

2. The FDA recommends clinicians or researchers use stool donated before Dec. 1, 2019, whenever possible.

3. If stool from before Dec. 1 is not available, clinicians or researchers should screen donors for COVID-19, test donors or the stool for COVID-19, and develop informed consent forms that warn of potential transmission.

Read the entire briefing here.

More articles on ASC news:
Regent Surgical Health responds to COVID-19: 3 things to know
When will the coronavirus peak? It’s complicated
Hospitals looking into using ASCs for COVID-19 patients: 4 things to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.